5 Proven Reasons Families Choose the SmartSaveMeds Prescription Savings Program

Humira: With a retail cost over $7,300 per month, the program aims for a $0 cost, creating potential annual savings of $87,600.
Eliquis: A common blood thinner costing around $550 monthly could result in $6,600 in yearly savings.
Jardiance: This diabetes medication can cost nearly $700 per month, translating to over $8,200 in potential annual savings.

The usual advice for lowering prescription costs involves small tactics like switching to generics, using a free prescription discount card, or shopping around at different pharmacies. However, these can offer only modest relief, and they barely make a dent in the staggering expense of brand-name medications. For millions of Americans, particularly seniors on Medicare, a 20% discount on a $7,000 monthly drug is still completely unaffordable.

It’s no surprise that a recent survey found 43% of U.S. adults have skipped medication due to cost. The standard advice just isn't working. A more powerful but often overlooked solution involves working directly with drug manufacturers. This is the focus of SmartSaveMeds, a specialized service that has been helping families navigate these programs for over 22 years.

Approval is Not Guaranteed: SmartSaveMeds is an advocacy service that expertly manages your application. However, the final approval decision rests with the pharmaceutical manufacturers, whose criteria are often based on income and insurance details.
This Is a Paid Service: The $667 annual cost is a key consideration. This program is not a fit for those seeking savings on low-cost generic drugs, as the fee would outweigh the benefits. Its value is tied directly to high-cost, brand-name prescriptions.
The Process Takes Time: Unlike an instant discount at the counter, the enrollment and approval process typically takes two to three weeks. It is designed for managing ongoing medication costs, not for a prescription you need to fill immediately.